Deadline Approaching for ATTR Early-Career Research Forum Submissions with Two Major Awards
As the innovative landscape of medical research continues to evolve, opportunities for early-career investigator involvement become vital. One such opportunity is the upcoming 3rd Annual ATTR Early-Career Research Forum, which is set to recognize and promote emerging talent in amyloidosis research. With the submission deadline fast approaching on October 2, 2026, physician-scientists in the US are urged to submit their research abstracts to seize this pivotal platform.
The forum, sponsored by Cornerstone Medical Education in collaboration with AstraZeneca and Ionis Pharmaceuticals, aims to inspire, equip, and connect the next generation of ATTR researchers. It serves not only as an avenue to present research but also as a unique chance to engage with experienced leaders in the field. Past participants have praised the forum's ability to foster scientific connections and provide valuable feedback essential for their professional development.
Dr. Evangelos Oikonomou of Yale School of Medicine, a previous recipient of the Wiesman Award, reflected on the lasting impact of participating in the forum, stating, "As an early-career investigator, I particularly value the opportunity to present my research, receive thoughtful feedback from leaders in the field, and form new scientific connections." This sentiment underscores the importance of collaboration within the ATTR research community. Oikonomou noted that the award not only provided him with financial support but also enhanced his visibility within the research space, encouraging his ongoing commitment to innovative pursuits, such as improving the early detection of transthyretin cardiac amyloidosis.
The forum will invite the top four investigators selected through a rigorous blinded review process to present their research during a live virtual event scheduled for October 29, 2026, from 5:00 PM to 7:00 PM ET. Among these presenters, the two highest-scoring individuals, as decided by the Co-Chairs, will each be honored with a $100,000 Wiesman Award for Excellence in Early-Career ATTR Research. This award is named in tribute to Dr. Janice Wiesman, a pioneering figure in the field.
Eligible early-career physician-scientists should not hesitate to apply. Dr. Oikonomou encouraged his peers by stating, "I would strongly encourage other young investigators to submit their abstracts." The forum represents much more than an academic exercise; it embodies a comprehensive initiative to advance research in ATTR amyloidosis, ultimately aiming to enhance patient outcomes.
In conclusion, with only one month left for submissions and exciting potential for career advancement through awards and connections, this forum presents an invaluable opportunity for budding researchers in the field of amyloidosis. The commitment of Cornerstone Medical Education and its partners reaffirms the importance of nurturing young talent and driving innovation that translates into tangible health benefits. Researchers should prepare their abstracts and remember that together, they can foster a robust, collaborative environment that pushes the boundaries of scientific discovery in the realm of cardiac amyloidosis and beyond.
The forum, sponsored by Cornerstone Medical Education in collaboration with AstraZeneca and Ionis Pharmaceuticals, aims to inspire, equip, and connect the next generation of ATTR researchers. It serves not only as an avenue to present research but also as a unique chance to engage with experienced leaders in the field. Past participants have praised the forum's ability to foster scientific connections and provide valuable feedback essential for their professional development.
Dr. Evangelos Oikonomou of Yale School of Medicine, a previous recipient of the Wiesman Award, reflected on the lasting impact of participating in the forum, stating, "As an early-career investigator, I particularly value the opportunity to present my research, receive thoughtful feedback from leaders in the field, and form new scientific connections." This sentiment underscores the importance of collaboration within the ATTR research community. Oikonomou noted that the award not only provided him with financial support but also enhanced his visibility within the research space, encouraging his ongoing commitment to innovative pursuits, such as improving the early detection of transthyretin cardiac amyloidosis.
The forum will invite the top four investigators selected through a rigorous blinded review process to present their research during a live virtual event scheduled for October 29, 2026, from 5:00 PM to 7:00 PM ET. Among these presenters, the two highest-scoring individuals, as decided by the Co-Chairs, will each be honored with a $100,000 Wiesman Award for Excellence in Early-Career ATTR Research. This award is named in tribute to Dr. Janice Wiesman, a pioneering figure in the field.
Eligible early-career physician-scientists should not hesitate to apply. Dr. Oikonomou encouraged his peers by stating, "I would strongly encourage other young investigators to submit their abstracts." The forum represents much more than an academic exercise; it embodies a comprehensive initiative to advance research in ATTR amyloidosis, ultimately aiming to enhance patient outcomes.
In conclusion, with only one month left for submissions and exciting potential for career advancement through awards and connections, this forum presents an invaluable opportunity for budding researchers in the field of amyloidosis. The commitment of Cornerstone Medical Education and its partners reaffirms the importance of nurturing young talent and driving innovation that translates into tangible health benefits. Researchers should prepare their abstracts and remember that together, they can foster a robust, collaborative environment that pushes the boundaries of scientific discovery in the realm of cardiac amyloidosis and beyond.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.